AAV-CMV-iCre (AAV Serotype 2)

Product Category: Pre-made recombinant AAV; AAV-CMV-iCre; AAV-iCre; AAV2-CMV-iCre; AAV2-iCre

Description:
Cre recombinase is a type I topoisomerase from bacteriophage P1 that catalyzes the site-specific recombination of DNA between loxP sites. Cre recombinase is used as a tool to genetically modify genes, such as to delete a segment of DNA flanked by LoxP sites in cells or experimental animals. By optimizing the mammalian codon usage for Cre recombinase, Cre expression is improved in the mammalian cells. This codon-improved Cre (known as iCre) transgene shows lower CpG content from the prokaryotic coding sequence, thus reducing the chances of epigenetic silencing in mammals.

AAV2-CMV-iCre is a pre-packaged rAAV in serotype 2 (with capsid from AAV serotype 2 and 2xITR from AAV serotype 2) which over-expresses iCre recombinase under CMV promoter. This product used in the Cre-lox system as a genetic tool to generate site-specific recombination of DNA between loxP sites in cultured cells and animal experiments. Ready to use format.

Titer: >1E+13 VG/mL

Size: > 30 µL (Std Pack)

Reconstitution Buffer: Sterile PBS supplemented with final 0.005% Pluronic F-68 and 200 mM NaCl

Infection Protocol:

Vector Map: